Navigation Links
Donald A. Deieso, Ph.D., Chairman & CEO, PeriGen, Inc. Named Ernst & Young Entrepreneur Of The Year 2010 Award Finalist

PeriGen, Inc., the only OB-specific risk reduction company to provide solutions which generate immediate quantifiable clinical and financial value, today announced that Donald A. Deieso, Ph.D., the Company’s Chairman & CEO, is a finalist for the Ernst & Young Entrepreneur Of The Year 2010 Award in New Jersey.

Princeton, NJ -- PeriGen, Inc., the only OB-specific risk reduction company to provide solutions which generate immediate quantifiable clinical and financial value, today announced that Donald A. Deieso, Ph.D., the Company’s Chairman & CEO, is a finalist for the Ernst & Young Entrepreneur Of The Year 2010 Award in New Jersey. According to Ernst & Young LLP, the awards program recognizes entrepreneurs who demonstrate extraordinary success in the areas of innovation, financial performance and personal commitment to their businesses and communities. Dr. Deieso was selected as a finalist from over 40 nominations by a panel of independent judges. Award winners will be announced at a special gala event on Thursday, June 24th at The Teaneck Marriott at Glenpointe, NJ.

“As the Chairman and CEO of PeriGen, a company dedicated to reducing the risks associated with childbirth, preventing medical errors in OB, and improving the quality of care delivered to mothers and babies, I can tell you with certainty that doing good can also be good for business,” said Dr. Deieso. ''It is an honor to be recognized by Ernst & Young, and a privilege to be considered for the prestigious Entrepreneur Of The Year Award. I am delighted to be included in such fine company as the finalists and past recipients of this award.''

PeriGen is a technology-enabled solutions firm, providing a full suite of consulting and professional services to improve outcomes and increase patient safety in OB. PeriGen’s advanced clinical decision support and fetal monitoring solutions combine patient data with evidence-based guidelines to generate real-time prompts, alerts, and reminders at the patient’s bedside. Providing a virtual “safety net” for both patients and clinicians, PeriGen helps to ensure the early identification of potential problems, leading to swift intervention and better clinical outcomes. PeriGen’s solutions include the use of advanced, proprietary reporting and analytics tools, which help client hospitals drive a cycle of continuous quality improvement, and achieve the highest standard of patient care.

The Ernst & Young Entrepreneur Of The Year awards program celebrates its 24th anniversary this year. The program has expanded to recognize business leaders in over 135 cities in 50 countries throughout the world.

Regional award winners are eligible for consideration for the Ernst & Young LLP Entrepreneur Of The Year national program. Award winners in several national categories, as well as the overall national Ernst & Young Entrepreneur Of The Year award winner, will be announced at the annual awards gala in Palm Springs, California on November 13, 2010. The awards are the culminating event of the Ernst & Young Strategic Growth Forum, the nation’s most prestigious gathering of high-growth, market-leading companies.

About PeriGen, Inc.
PeriGen is a technology-enabled professional services company specializing in risk reduction and clinical quality improvement in Obstetrics. Singularly focused on reducing risk and improving financial performance, PeriGen’s clinical decision support and fetal monitoring solutions are installed in over 100 hospitals across North America. A pioneer in clinical decision support, PeriGen provides innovative solutions and a full suite of complementary professional and consulting services that reduce risk and improve clinical outcomes. PeriGen is a US corporation headquartered in Princeton, New Jersey, with offices in Canada and Israel. For more information, please visit us at

About Ernst & Young’s Entrepreneur Of The Year Awards Program
Ernst & Young’s Entrepreneur Of The Year is the world’s most prestigious business award for entrepreneurs. The award makes a difference through the unique way it encourages entrepreneurial activity among those with potential and recognizes the contribution of people who inspire others with their vision, leadership and achievement. As the first and only truly global award of its kind, Ernst & Young Entrepreneur Of The Year celebrates those who are building and leading successful, growing and dynamic businesses, recognizing them through regional, national and global awards programs in more than 135 cities in 50 countries.

Ernst & Young refers to the global organization of member firms of Ernst & Young Global Limited, each of which is a separate legal entity. Ernst & Young LLP is a client-serving member firm of Ernst & Young Global Limited located in the U.S.

Awards Program Sponsors
Founded and produced by Ernst & Young LLP, the Entrepreneur Of The Year awards are pleased to have the Ewing Marion Kauffman Foundation and SAP America as national sponsors. In New Jersey, sponsors include regional sponsors Bowne & Co and Morgan, Lewis & Bockius LLP and local sponsors Gibbons P.C., NJBIZ, NJTC and WithumSmith+Brown.


Read the full story at

Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Executive Chairman of Medifast Bradley T. MacDonald Graduates From Leadership Maryland Class of 2009
2. The Chicago Office of McDonald Hopkins Continues to Expand: Healthcare Attorney, Charles F. MacKelvie, Joins the Firms National Healthcare and Healthcare Restructuring Practice Groups
3. Ronald McDonald House Charities(R) (RMHC(R)) Awards Nearly $3 Million to Non-Profit Organizations
4. Ronald McDonald Care Mobile(R) Brings Dental Care to Area Schools
5. Dr. Michael Macdonald Named Best Plastic Surgeon in San Francisco Bay Area
6. ASTRO applauds nomination of Dr. Donald Berwick to head Centers for Medicare and Medicaid Services
7. Karmanos Cancer Institute in Detroit Names Gerold Bepler, M.D., Ph.D., as CEO
8. DNC Chairman Tim Kaine Calls Senate Vote Historic, Says Landmark Health Reform Bill Is a Victory for the American People
9. Gene Barduson Named Chairman of PerfectServe Board of Directors
10. U.S. Preventive Medicine Appoints Ron Loeppke, MD, MPH, as Vice Chairman of the Board
11. Senator Janis Lee Sponsors Senate Resolution Supporting Kevin Saunders for Chairman of the President's Council on Physical Fitness & Sports
Post Your Comments:
Related Image:
Donald A. Deieso, Ph.D., Chairman & CEO, PeriGen, Inc. Named Ernst & Young Entrepreneur Of The Year 2010 Award Finalist 
(Date:12/1/2015)... , ... December 01, 2015 , ... ... of Excellence (BHCOE) today announced that the organization has awarded Education and Developmental ... with a Distinguished Award. The award celebrates exceptional special needs providers that excel ...
(Date:12/1/2015)... MA (PRWEB) , ... December 01, 2015 , ... Lutronic, ... release of Clarity, the latest addition to the devices for sale in the United ... 755 nm Alexandrite and long-pulsed 1064 nm Nd:YAG lasers, into a single platform that ...
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... XTC ... selected 10 semi-finalists to head to Las Vegas for CES 2016, the world’s largest ... CEO of Consumer Technology Association Gary Shapiro, Founding Partner of Pacific Investments Veronica Serra, ...
(Date:12/1/2015)... ... , ... Nurotron Biotechnology Co., Ltd., maker of cochlear implant systems, has won ... order will be from the China Disabled Persons’ Federation, a central government association, for ... for children and adults suffering from severe and profound hearing loss . The ...
(Date:12/1/2015)... IL (PRWEB) , ... December 01, 2015 , ... ... Unified Contact Center Enterprise Authorized Technology Provider (ATP) status from Cisco. This designation ... deploy and support Cisco Unified Contact Center solutions targeted to the high-end enterprise ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... December 1, 2015 --> ... research report "Nucleic Acid Labeling Market by Product (Reagents ... Random Primer, In Vitro Transcription, Reverse Transcription, End Labeling), ... MarketsandMarkets, The global market is expected to reach USD ... 2015, growing at a CAGR of 8.65%. ...
(Date:12/1/2015)... , Dec. 01, 2015 ... announced the addition of the ... Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, ... report to their offering. --> ... addition of the "2016 Europe ...
(Date:12/1/2015)... ANGELES , Dec. 1, 2015 CytRx ... development company specializing in oncology, today announced that it ... the company,s pivotal global Phase 3 clinical trial of ... (STS). Enrollment was originally estimated to be completed in Q1 ... being conducted under a Special Protocol Assessment from the ...
Breaking Medicine Technology: